Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis

(2010) Nicolas Vuilleumier et al.   ARTHRITIS AND RHEUMATISM

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus

(2010) Sean G. O'Neill et al.   ARTHRITIS AND RHEUMATISM

Imaging of the Fibrous Cap in Atherosclerotic Carotid Plaque

(2010) Luca Saba et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction

(2010) N. Vuilleumier et al.   EUROPEAN HEART JOURNAL

The metabolic syndrome

(2010) Robert H Eckel et al.   LANCET

Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke

(2010) Fabrizio Montecucco et al.   STROKE

HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis

(2009) Eirini M. Tsompanidi et al.   ATHEROSCLEROSIS

Inflammation in Atherosclerosis

(2009) Peter Libby et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Innate and adaptive immunity in atherosclerosis

(2009) René R. S. Packard et al.   Seminars in Immunopathology

Intravenous immunoglobulin — Indications and mechanisms in cardiovascular diseases

(2008) Nussinovitch Udi et al.   AUTOIMMUNITY REVIEWS

Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome

(2008) Nicolas Vuilleumier et al.   CLINICAL SCIENCE

Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis

(2007) Alma Zernecke et al.   CIRCULATION RESEARCH